Tags

Type your tag names separated by a space and hit enter

Awareness, trial and use of heated tobacco products among adult cigarette smokers and e-cigarette users: findings from the 2018 ITC Four Country Smoking and Vaping Survey.
Tob Control. 2022 01; 31(1):11-18.TC

Abstract

OBJECTIVE

To evaluate heated tobacco product (HTP) awareness, trial and current use among adult cigarette smokers and vaping product users in four countries with varying regulations governing HTP sales.

DESIGN

Data came from Wave 2 of the ITC Four Country Smoking and Vaping Survey, collected from February to July 2018. Respondents were current and former smokers and/or users of vaping products (18 years or older) from Canada (CA; n=3778), England (EN; n=4848), the USA (US; n=2846) and Australia (AU; n=1515). At the time of the survey, only Canada and England permitted the sale of contemporary HTPs (eg, IQOS).

RESULTS

Overall, 30.2% of respondents reported being aware of HTPs (CA=30.4%; EN=31.0%; US=30.2%; AU=27.4%; p=0.346), 2.4% had ever tried HTPs (CA=3.3%; EN=2.4%; US=2.0%; AU=0.9%; p=0.001) and 0.9% currently used HTPs at least monthly (CA=0.8%; EN=1.2%; US=0.7%; AU=0.2%; p<0.001). Trial and current use were higher among those who concurrently smoked and vaped (at least monthly) versus other nicotine use categories (trial: 10.9% v. 1.2%-2.0%, p<0.001; current use: 8.4% v. 0.1%-1.0%, p<0.001). In multivariable analyses, HTP awareness did not differ across countries, whereas odds of trial and current use were lower where HTPs were unavailable. Odds of HTP trial did not differ by regulatory environment when restricting analysis to HTP-aware concurrent smokers-vapers.

CONCLUSION

Approximately one third of respondents were aware of HTPs, even in the USA and Australia, where contemporary HTPs were not yet on the market. Trial and use were uncommon, except among concurrent smokers-vapers. Restrictions on availability may have limited HTP use generally, but less so for concurrent smokers-vapers.

Authors+Show Affiliations

Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.Department of Addictions, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.Department of Psychology, University of Waterloo, Waterloo, Ontario, Canada.School of Psychology, Deakin University, Geelong, Victoria, Australia.School of Psychological Sciences, University of Melbourne, Melbourne, Victoria, Australia.Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.Department of Psychology, University of Waterloo, Waterloo, Ontario, Canada. Ontario Institute for Cancer Research, Toronto, Ontario, Canada.Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.Department of Psychology, University of Waterloo, Waterloo, Ontario, Canada.Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA maciej.goniewicz@roswellpark.org.

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

32994299

Citation

Miller, Connor R., et al. "Awareness, Trial and Use of Heated Tobacco Products Among Adult Cigarette Smokers and E-cigarette Users: Findings From the 2018 ITC Four Country Smoking and Vaping Survey." Tobacco Control, vol. 31, no. 1, 2022, pp. 11-18.
Miller CR, Sutanto E, Smith DM, et al. Awareness, trial and use of heated tobacco products among adult cigarette smokers and e-cigarette users: findings from the 2018 ITC Four Country Smoking and Vaping Survey. Tob Control. 2022;31(1):11-18.
Miller, C. R., Sutanto, E., Smith, D. M., Hitchman, S. C., Gravely, S., Yong, H. H., Borland, R., O'Connor, R. J., Cummings, K. M., Fong, G. T., Hyland, A., Quah, A. C. K., & Goniewicz, M. L. (2022). Awareness, trial and use of heated tobacco products among adult cigarette smokers and e-cigarette users: findings from the 2018 ITC Four Country Smoking and Vaping Survey. Tobacco Control, 31(1), 11-18. https://doi.org/10.1136/tobaccocontrol-2020-055985
Miller CR, et al. Awareness, Trial and Use of Heated Tobacco Products Among Adult Cigarette Smokers and E-cigarette Users: Findings From the 2018 ITC Four Country Smoking and Vaping Survey. Tob Control. 2022;31(1):11-18. PubMed PMID: 32994299.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Awareness, trial and use of heated tobacco products among adult cigarette smokers and e-cigarette users: findings from the 2018 ITC Four Country Smoking and Vaping Survey. AU - Miller,Connor R, AU - Sutanto,Edward, AU - Smith,Danielle M, AU - Hitchman,Sara C, AU - Gravely,Shannon, AU - Yong,Hua H, AU - Borland,Ron, AU - O'Connor,Richard J, AU - Cummings,K Michael, AU - Fong,Geoffrey T, AU - Hyland,Andrew, AU - Quah,Anne C K, AU - Goniewicz,Maciej L, Y1 - 2020/09/29/ PY - 2020/06/04/received PY - 2020/08/04/revised PY - 2020/08/19/accepted PY - 2020/10/1/pubmed PY - 2022/4/26/medline PY - 2020/9/30/entrez KW - electronic nicotine delivery devices KW - harm reduction KW - non-cigarette tobacco products KW - public policy KW - surveillance and monitoring SP - 11 EP - 18 JF - Tobacco control JO - Tob Control VL - 31 IS - 1 N2 - OBJECTIVE: To evaluate heated tobacco product (HTP) awareness, trial and current use among adult cigarette smokers and vaping product users in four countries with varying regulations governing HTP sales. DESIGN: Data came from Wave 2 of the ITC Four Country Smoking and Vaping Survey, collected from February to July 2018. Respondents were current and former smokers and/or users of vaping products (18 years or older) from Canada (CA; n=3778), England (EN; n=4848), the USA (US; n=2846) and Australia (AU; n=1515). At the time of the survey, only Canada and England permitted the sale of contemporary HTPs (eg, IQOS). RESULTS: Overall, 30.2% of respondents reported being aware of HTPs (CA=30.4%; EN=31.0%; US=30.2%; AU=27.4%; p=0.346), 2.4% had ever tried HTPs (CA=3.3%; EN=2.4%; US=2.0%; AU=0.9%; p=0.001) and 0.9% currently used HTPs at least monthly (CA=0.8%; EN=1.2%; US=0.7%; AU=0.2%; p<0.001). Trial and current use were higher among those who concurrently smoked and vaped (at least monthly) versus other nicotine use categories (trial: 10.9% v. 1.2%-2.0%, p<0.001; current use: 8.4% v. 0.1%-1.0%, p<0.001). In multivariable analyses, HTP awareness did not differ across countries, whereas odds of trial and current use were lower where HTPs were unavailable. Odds of HTP trial did not differ by regulatory environment when restricting analysis to HTP-aware concurrent smokers-vapers. CONCLUSION: Approximately one third of respondents were aware of HTPs, even in the USA and Australia, where contemporary HTPs were not yet on the market. Trial and use were uncommon, except among concurrent smokers-vapers. Restrictions on availability may have limited HTP use generally, but less so for concurrent smokers-vapers. SN - 1468-3318 UR - https://www.unboundmedicine.com/medline/citation/32994299/Awareness_trial_and_use_of_heated_tobacco_products_among_adult_cigarette_smokers_and_e_cigarette_users:_findings_from_the_2018_ITC_Four_Country_Smoking_and_Vaping_Survey_ DB - PRIME DP - Unbound Medicine ER -